Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell LeukaemiaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphoproliferative syndrome, neoplasm, plasma cell leukemia, plasma cell neoplasmNot yet recruitingPhase 22025-04-25NCT06830733

1 results · Page 1 of 1

Swipe the table sideways for more columns.

7 results · Page 1 of 1

Swipe the table sideways for more columns.